80 FR 8332 - National Institute on Drug Abuse; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 80, Issue 31 (February 17, 2015)
National Institutes of Health
Federal Register Volume 80, Issue 31 (February 17, 2015)
| Page Range | 8332-8332 | |
| FR Document | 2015-03095 |
[Federal Register Volume 80, Number 31 (Tuesday, February 17, 2015)] [Notices] [Page 8332] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-03095] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Extracellular Vesicles in HIV/AIDS and Substance Abuse (R01, R21). Date: February 26, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Jagadeesh S. Rao, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 4234, MSC 9550, Bethesda, MD 02892, 301-443-9511, [email protected]. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R21/R33). Date: March 3, 2015. Time: 12:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Jagadeesh S. Rao, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 4234, MSC 9550, Bethesda, MD 02892, 301-443-9511, [email protected]. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA Core ``Center of Excellence'' Grant Program (P30). Date: March 10, 2015. Time: 8:30 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: NIAID Conference Center, 5609 Fisher's Lane, Rockville, MD 20852. Contact Person: Nadine Rogers, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4229, MSC 9550, Bethesda, MD 20892- 9550, 301-402-2105, [email protected]. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA Research ``Center of Excellence'' Grant Program (P50). Date: March 11, 2015. Time: 8:30 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: NIAID Conference Center, 5609 Fisher's Lane, Rockville, MD 20852. Contact Person: Nadine Rogers, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4229, MSC 9550, Bethesda, MD 20892- 9550, 301-402-2105, [email protected]. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; R13 Conference Grant Review (PA13-347). Date: March 17, 2015. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Virtual Meeting). Contact Person: Minna Liang, Ph.D., Scientific Review Officer, Grants Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4226, MSC 9550, Bethesda, MD 20892-9550, 301-435-1432, [email protected]. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Loan Repayment 2015. Date: March 30, 2015. Time: 9:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Virtual Meeting). Contact Person: Lyle Furr, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892- 9550, (301) 435-1439, lf33c.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Interventions for Youth Who Misuse/Abuse Prescription Stimulant Medications in High School and/or College- Attending Youth (U01). Date: March 31, 2015. Time: 8:30 a.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, Bethesda, MD 20814. Contact Person: Susan O. McGuire, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., Room 4245, Rockville, MD 20852, 301-435-1426, [email protected]. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; The National Drug Abuse Treatment Clinical Trials Network (UG1). Date: March 31, 2015. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Contact Person: Jose F. Ruiz, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, (301) 451-3086, [email protected]. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP2). Date: April 13, 2015. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, Bethesda, MD 20814. Contact Person: Gerald L. McLaughlin, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4238, MSC 9550, Bethesda, MD 20892-9550, 301-402-6626, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: February 9, 2015. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015-03095 Filed 2-13-15; 8:45 am] BILLING CODE 4140-01-P
![8332 Federal Register / Vol. 80, No. 31 / Tuesday, February 17, 2015 / Notices
93.393, Cancer Cause and Prevention Boulevard, Rockville, MD 20852, (Telephone DHHS, Room 4227, MSC 9550, 6001
Research; 93.394, Cancer Detection and Conference Call). Executive Boulevard, Bethesda, MD 20892–
Diagnosis Research; 93.395, Cancer Contact Person: Jagadeesh S. Rao, Ph.D., 9550, (301) 435–1439, lf33c.nih.gov.
Treatment Research; 93.396, Cancer Biology Scientific Review Officer, Office of
Research; 93.397, Cancer Centers Support; Name of Committee: National Institute on
Extramural Affairs, National Institute on
93.398, Cancer Research Manpower; 93.399, Drug Abuse, National Institutes of Health, Drug Abuse Special Emphasis Panel;
Cancer Control, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room Interventions for Youth Who Misuse/Abuse
HHS) 4234, MSC 9550, Bethesda, MD 02892, 301– Prescription Stimulant Medications in High
Dated: February 10, 2015. 443–9511, jrao@nida.nih.gov. School and/or College-Attending Youth
Name of Committee: National Institute on (U01).
Melanie J. Gray,
Drug Abuse Special Emphasis Panel; NIDA Date: March 31, 2015.
Program Analyst, Office of Federal Advisory Core ‘‘Center of Excellence’’ Grant Program Time: 8:30 a.m. to 4:30 p.m.
Committee Policy. (P30). Agenda: To review and evaluate grant
[FR Doc. 2015–03092 Filed 2–13–15; 8:45 am] Date: March 10, 2015. applications.
BILLING CODE 4140–01–P Time: 8:30 a.m. to 4:00 p.m. Place: Hilton Garden Inn Bethesda, 7301
Agenda: To review and evaluate grant Waverly Street, Bethesda, MD 20814.
applications.
Contact Person: Susan O. McGuire, Ph.D.,
DEPARTMENT OF HEALTH AND Place: NIAID Conference Center, 5609
Scientific Review Officer, Office of
HUMAN SERVICES Fisher’s Lane, Rockville, MD 20852.
Contact Person: Nadine Rogers, Ph.D., Extramural Affairs, National Institute on
Scientific Review Officer, Office of Drug Abuse, National Institutes of Health,
National Institutes of Health
Extramural Affairs, National Institute on DHHS, 6001 Executive Blvd., Room 4245,
National Institute on Drug Abuse; Drug Abuse, NIH, DHHS, 6001 Executive Rockville, MD 20852, 301–435–1426,
Notice of Closed Meetings Blvd., Room 4229, MSC 9550, Bethesda, MD mcguireso@mail.nih.gov.
20892–9550, 301–402–2105, rogersn2@ Name of Committee: National Institute on
Pursuant to section 10(d) of the nida.nih.gov. Drug Abuse Special Emphasis Panel; The
Federal Advisory Committee Act, as Name of Committee: National Institute on National Drug Abuse Treatment Clinical
amended (5 U.S.C. App), notice is Drug Abuse Special Emphasis Panel; NIDA Trials Network (UG1).
hereby given of the following meetings. Research ‘‘Center of Excellence’’ Grant Date: March 31, 2015.
The meetings will be closed to the Program (P50).
Time: 8:30 a.m. to 5:00 p.m.
public in accordance with the Date: March 11, 2015.
Time: 8:30 a.m. to 4:00 p.m. Agenda: To review and evaluate
provisions set forth in sections cooperative agreement applications.
552b(c)(4) and 552b(c)(6), title 5 U.S.C., Agenda: To review and evaluate grant
applications. Place: National Institutes of Health,
as amended. The grant applications and Place: NIAID Conference Center, 5609 Neuroscience Center, 6001 Executive
the discussions could disclose Fisher’s Lane, Rockville, MD 20852. Boulevard, Rockville, MD 20852.
confidential trade secrets or commercial Contact Person: Nadine Rogers, Ph.D., Contact Person: Jose F. Ruiz, Ph.D.,
property such as patentable material, Scientific Review Officer, Office of Scientific Review Officer, Office of
and personal information concerning Extramural Affairs, National Institute on Extramural Affairs, National Institute on
individuals associated with the grant Drug Abuse, NIH, DHHS, 6001 Executive Drug Abuse, NIH, Room 4228, MSC 9550,
applications, the disclosure of which Blvd., Room 4229, MSC 9550, Bethesda, MD 6001 Executive Blvd., Bethesda, MD 20892–
would constitute a clearly unwarranted 20892–9550, 301–402–2105, rogersn2@
9550, (301) 451–3086, ruizjf@nida.nih.gov.
invasion of personal privacy. nida.nih.gov.
Name of Committee: National Institute on Name of Committee: National Institute on
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; R13 Drug Abuse Special Emphasis Panel; Avenir
Drug Abuse Special Emphasis Panel; Conference Grant Review (PA13–347). Award Program for Genetics or Epigenetics of
Extracellular Vesicles in HIV/AIDS and Date: March 17, 2015. Substance Abuse (DP2).
Substance Abuse (R01, R21). Time: 2:00 p.m. to 4:00 p.m. Date: April 13, 2015.
Date: February 26, 2015.
Agenda: To review and evaluate grant Time: 9:00 a.m. to 5:00 p.m.
Time: 8:00 a.m. to 5:00 p.m.
applications. Agenda: To review and evaluate grant
Agenda: To review and evaluate grant
Place: National Institutes of Health, applications.
applications.
Neuroscience Center, 6001 Executive Place: Hilton Garden Inn Bethesda, 7301
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852. Boulevard, Rockville, MD 20852, (Virtual Waverly Street, Bethesda, MD 20814.
Contact Person: Jagadeesh S. Rao, Ph.D., Meeting).
Contact Person: Gerald L. McLaughlin,
Scientific Review Officer, Office of Contact Person: Minna Liang, Ph.D.,
Scientific Review Officer, Grants Review Ph.D., Scientific Review Officer, Office of
Extramural Affairs, National Institute on Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health, Branch, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH, Drug Abuse, NIH, DHHS, 6001 Executive
DHHS, 6001 Executive Boulevard, Room
DHHS, 6001 Executive Blvd., Room 4226, Blvd., Room 4238, MSC 9550, Bethesda, MD
4234, MSC 9550, Bethesda, MD 02892, 301–
443–9511, jrao@nida.nih.gov. MSC 9550, Bethesda, MD 20892–9550, 301– 20892–9550, 301–402–6626, gm145a@
This notice is being published less than 15 435–1432, liangm@nida.nih.gov. nih.gov.
days prior to the meeting due to the timing Name of Committee: National Institute on (Catalogue of Federal Domestic Assistance
limitations imposed by the review and Drug Abuse Special Emphasis Panel; Loan Program Nos.: 93.279, Drug Abuse and
funding cycle. Repayment 2015. Addiction Research Programs, National
Name of Committee: National Institute on Date: March 30, 2015. Institutes of Health, HHS)
Drug Abuse Special Emphasis Panel; Time: 9:00 a.m. to 2:00 p.m.
Exploratory Studies of Smoking Cessation Agenda: To review and evaluate grant Dated: February 9, 2015.
applications.
tkelley on DSK3SPTVN1PROD with NOTICES
Interventions for People with Schizophrenia Michelle Trout,
(R21/R33). Place: National Institutes of Health,
Program Analyst, Office of Federal Advisory
Date: March 3, 2015. Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Virtual Committee Policy.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant Meeting). [FR Doc. 2015–03095 Filed 2–13–15; 8:45 am]
applications. Contact Person: Lyle Furr, Scientific BILLING CODE 4140–01–P
Place: National Institutes of Health, Review Officer, Office of Extramural Affairs,
Neuroscience Center, 6001 Executive National Institute on Drug Abuse, NIH,
VerDate Sep<11>2014 16:51 Feb 13, 2015 Jkt 235001 PO 00000 Frm 00048 Fmt 4703 Sfmt 9990 E:\FR\FM\17FEN1.SGM 17FEN1](https://thefederalregister.org/doc/80_FR_8363/page/1.svg)
Document Created: 2015-12-18 13:19:40
Document Modified: 2015-12-18 13:19:40
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | February 26, 2015. | |
| FR Citation | 80 FR 8332 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR